Pay in 4 interest-free payments of $7.09 Learn more
Ships within 48 hours · Estimated delivery Sep 26 - Oct 1
Frequently Asked Questions (FAQ) Q1: How fast does BPC-157 work for ulcers
TB-500 and Thymosin Beta-4 are also prohibited by WADA/USADA under S2 (Peptide Hormones, Growth Factors, Related Substances and Mimetics), applicable at all times both in-competition and out-of-competition TB-500 / Thymosin Beta-4 Clinical Trials: The RGN-352 and RGN-259 Programs RegeneRx Biopharmaceuticals has pursued two clinical development programs for Thymosin Beta-4, providing the most substantial human clinical data available for any TB-500-related compound: RGN-352 (Injectable Thymosin Beta-4 for Cardiac Repair): Phase 1 trial (completed): A double-blind, placebo-controlled study enrolled 40 healthy volunteers across four cohorts of 10 subjects each, testing escalating dose levels of intravenous Thymosin Beta-4 administered daily over 14 days
In addition to continuing reports from Sikiric et al, one group has shown that BPC 157 improves rat tendon growth using a cell model, while another group demonstrated that it is not toxic in dogs
No rounding
If you experience these or any other side effects after receiving an injection, contact your doctor as soon as possible
Hospira is manufactured in FDA-registered facilities to USP standards
